Jiayu Chen

发表

30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease

Wei Wang, Weiqi Wang, Yan Li, 2022, Frontiers in Oncology.

The prognostic factors in acute myeloid leukaemia with double‐mutated CCAAT/enhancer‐binding protein alpha (CEBPAdm)

Yan Li, Jianxiang Wang, Y. Mi, 2022, British journal of haematology.

CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells

Yiping Wen, Tiantian Han, Yan Li, 2022, BMC Cancer.

Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical Trial

Yan Li, Ting Li, Siying Peng, 2022, Cancers.

Abstract. Sirtuin 1 (SIRT1), a member of the sirtuin protein family, is a nicotinamide adenine dinucleotide (NAD+)‐dependent type III histone deacetylase and mono‐ADP‐ribosyltransferase. SIRT1 can deacetylate

L. Pan, Houzao Chen, Jiayu Chen, 2021 .

A Comparison of Laparoscopies and Laparotomies for Radical Hysterectomy in Stage IA1-IB1 Cervical Cancer Patients: A Single Team With 18 Years of Experience

Wei Wang, Yan Li, Yu Gu, 2020, Frontiers in Oncology.

Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases

Wei Wang, Yan Li, Yu Gu, 2021, Frontiers in Oncology.

Systematic Lymph Node Dissection May Be Abolished in Patients With Apparent Early-Stage Low-Grade Mucinous and Endometrioid Epithelial Ovarian Cancer

Wei Wang, Yan Li, L. Pan, 2021, Frontiers in Oncology.

SIRT1 and gynecological malignancies

L. Pan, Houzao Chen, Jiayu Chen, 2021, Oncology reports.

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer

Y. You, Siyi Li, Yan Li, 2021, Frontiers in Oncology.